about
Plasma interleukin 8 concentrations in obese subjects with impaired glucose toleranceHigh Serum IgG4 Concentrations in Patients with Hashimoto's Thyroiditis.Latent autoimmune diabetes in adults in a population-based cohort of Polish patients with newly diagnosed diabetes mellitus.The changes in the endothelial function and haemostatic and inflammatory parameters in subclinical and overt hyperthyroidism.Decreased Expression of Thyroglobulin and Sodium Iodide Symporter Genes in Hashimoto's Thyroiditis.Iodine deficiency disorders in the north-eastern region of Poland (Białystok coordinating center).Gammadelta T-cells alterations in the peripheral blood of high risk diabetes type 1 subjects with subclinical pancreatic B-cells impairment.Increased in vitro interleukin-12 production by peripheral blood in high-risk IDDM first degree relatives.Reference Values for TSH and Free Thyroid Hormones in Healthy Pregnant Women in Poland: A Prospective, Multicenter Study.HLA-DR, HLA-DQB1 and PTPN22 gene polymorphism: association with age at onset for autoimmune diabetes.Endothelial dysfunction in Graves' disease.Changes in tumor necrosis factor-alpha system and insulin sensitivity during an exercise training program in obese women with normal and impaired glucose tolerance.Serum L-selectin and ICAM-1 in patients with Graves' ophthalmopathy during treatment with corticosteroids.Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids.Circulating E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in men with coronary artery disease assessed by angiography and disturbances of carbohydrate metabolism.Increased plasma-soluble tumor necrosis factor-alpha receptor 2 level in lean nondiabetic offspring of type 2 diabetic subjects.Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system.Insulin resistance in the first-degree relatives of persons with type 2 diabetes.[Effect of beta-adrenergic blockade on cortisol secretion in insulin-induced hypoglycemia in animals with experimental diabetes mellitus][Effects of beta-selective blockade on levels of glucagon in blood plasma during insulin-induced hypoglycemia]CCN2 protein is an announcing marker for cardiac remodeling following STZ-induced moderate hyperglycemia in mice.Transcription factor 7-like 2-gene polymorphism is related to fasting C peptide in latent autoimmune diabetes in adults (LADA).[The possibility of prevention of type 2 diabetes].Glycosaminoglycans urinary excretion as a marker of the early stages of diabetic nephropathy and the disease progression.Plasma relaxin concentration is related to beta-cell function and insulin sensitivity in women with type 2 diabetes mellitus.Insulin resistance and fasting plasma glucose in first degree relatives of patients with type 1 diabetes.Decreased in vitro IL-4 [corrected] and IL-10 production by peripheral blood in first degree relatives at high risk of diabetes type-I.Recommendations of the Polish Society of Endocrinology and Polish Diabetes Association for the management of thyroid dysfunction in type 1 and type 2 diabetes.Prognostic markers for the development of type 1 diabetes in first-degree relatives of diabetic patients.Association between type 1 diabetes and periodontal health.[The C-peptide as a risk factor of development of type 1 diabetes in the first degree relatives of the autoimmunological diabetic patients].Levels of betatrophin decrease during pregnancy despite increased insulin resistance, beta-cell function and triglyceride levels.A pilot study of the effect of the glycosaminoglycan sulodexide on microalbuminuria in type I diabetic patients.40 EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 200435th Annual Meeting of the European Association for the Study of Diabetes : Brussels, Belgium, 28 September-2 October 199940th EASD Annual Meeting of the European Association for the Study of Diabetes35th Annual Meeting of the European Association for the Study of DiabetesOrally Given Nicotinamide Inhibits the Decreasing of Glutathione Content in the Pancreas of Streptozotocin Diabetic RatsSecretion and removal of insulin by dietThe increased activity of angiotensin-converting enzyme in patients with diabetes and nephropathy
P50
Q24803201-8713FF7B-5540-4AD9-B53C-FA235784C9C8Q35133828-71FF4576-9CD3-4267-8067-8CD3E857C8F9Q36105709-7F8E3DC9-A14F-48CD-97C2-8B8ACB97CB21Q37400614-BF05D502-1727-48C3-948A-67DD430F6E19Q38367800-95ED0221-653E-4F54-BF76-5B54E4559B7EQ39395852-3E78A84A-7998-407C-A597-798721344091Q40803883-C0E54498-AA25-4EBC-BED2-C4205A6673B0Q40898569-13435DB2-D868-43C1-B81C-B06FBB16030DQ41641255-E097632F-CBA7-44D9-893B-D716FD4C0C5EQ41895902-0839151E-6758-4F14-9613-5994F1435631Q43409927-35538AF3-785E-40CF-BFCD-8F9ECB209D1DQ43715717-23CB0069-31DE-4E34-8DC1-D5B87856255EQ43751943-29482FD8-C239-4DF1-A53F-22634965C969Q43831067-D98328F7-1C87-4CF1-ADC3-8F3DDFFEC1E8Q44011017-8565B2D3-1E99-46E3-8634-6B584A08AE77Q44155696-F2642FAC-63CA-48DE-BD37-875977DE6F95Q44168091-761F1A07-E1A0-4E1C-AF60-CD6E5BCD3A8AQ44450057-57C62BC5-52CB-4D28-974A-375503BC79C2Q44990663-E67F7D1C-077E-4155-8656-2987031EA22BQ45413966-C4B7C934-755C-4629-8F57-BFF90D0A2651Q45928263-319CD131-FC60-4E4E-9D6B-B50F11E07672Q45966411-55FB1B7C-AC5C-49EA-B3A8-367620B5401EQ46706641-7502E420-130D-4952-96D4-6A8CDEE1C7F4Q46754754-D9203F05-7D16-42BD-B94A-799475C265CAQ46884625-918E42F2-D5F0-4DDA-BC75-AF097BCA86BEQ47925609-A7713134-1828-4BF1-9812-A41D20ED2DF6Q50863715-2260F97D-C2E6-455D-B995-0A5AA990A707Q51251053-EDD15B2B-F5A2-46B9-A56D-BAAB9FD34679Q51320004-309EF8B5-72CB-43E3-B201-5539219C2099Q51323119-9183DE5E-340E-4A7A-BEFC-D04F224EB91CQ51413032-0351F62B-3221-4F7D-8005-22A0CE313ECFQ51553730-C9E9EFDF-8A42-4BCF-8344-2961E3F60CB9Q54704552-1E71278C-AA56-487D-A4A8-035665652EA8Q56836084-B70357C5-FFBD-4BFA-BA3F-0CC35A4D307DQ56883844-C7EDD8A9-5E3C-40E7-B56A-C1B8E04800D4Q57249806-38DA2B4D-75D9-4424-ACAB-843DF59F9203Q57920219-F3431372-A4CD-4359-9850-F0FF642B7FBCQ62034405-5773894E-39CC-42D4-9D28-CB9F3622880FQ68209277-3D1CA8E3-3B24-45D5-8EB2-BDCFD39D7506Q71340946-BFCCA452-FFAD-4312-9541-B226E8F5FFA8
P50
description
Polish endocrinologist and diabetologist
@en
Pools arts
@nl
investigador
@es
polska lekarka, endokrynolog i diabetolog
@pl
研究者
@zh
name
Malgorzata Szelachowska
@ast
Malgorzata Szelachowska
@es
Malgorzata Szelachowska
@nl
Małgorzata Szelachowska
@ca
Małgorzata Szelachowska
@cs
Małgorzata Szelachowska
@en
Małgorzata Szelachowska
@ga
Małgorzata Szelachowska
@gl
Małgorzata Szelachowska
@hr
Małgorzata Szelachowska
@hsb
type
label
Malgorzata Szelachowska
@ast
Malgorzata Szelachowska
@es
Malgorzata Szelachowska
@nl
Małgorzata Szelachowska
@ca
Małgorzata Szelachowska
@cs
Małgorzata Szelachowska
@en
Małgorzata Szelachowska
@ga
Małgorzata Szelachowska
@gl
Małgorzata Szelachowska
@hr
Małgorzata Szelachowska
@hsb
altLabel
Malgorzata Szelachowska
@en
Małgorzata Maria Szelachowska
@pl
prefLabel
Malgorzata Szelachowska
@ast
Malgorzata Szelachowska
@es
Malgorzata Szelachowska
@nl
Małgorzata Szelachowska
@ca
Małgorzata Szelachowska
@cs
Małgorzata Szelachowska
@en
Małgorzata Szelachowska
@ga
Małgorzata Szelachowska
@gl
Małgorzata Szelachowska
@hr
Małgorzata Szelachowska
@hsb
P214
P106
P1153
7003478306
P1412
P1559
Małgorzata Szelachowska
@pl
P21
P214
P27
P31
P3124
P3829
P496
0000-0001-5246-3435
P735
P7859
viaf-311812438